Exagen Inc.

NASDAQ: XGN · Real-Time Price · USD
9.70
0.35 (3.80%)
At close: Aug 15, 2025, 3:59 PM
9.49
-2.11%
After-hours: Aug 15, 2025, 04:18 PM EDT

Exagen Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
22.04M 36.49M 62.39M 99.44M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 200K 100K
Other Long-Term Assets
550K 616K 528K -391K
Receivables
7.83M 6.55M 6.08M 9.65M
Inventory
n/a 2.87M 1.79M 1.09M
Other Current Assets
6.58M 31K n/a n/a
Total Current Assets
36.45M 47.84M 72.61M 112.73M
Property-Plant & Equipment
7.68M 8.49M 13.08M 4.77M
Goodwill & Intangibles
n/a n/a -1.61M 5.51M
Total Long-Term Assets
8.23M 9.1M 13.61M 10.71M
Total Assets
44.69M 56.94M 86.22M 123.44M
Account Payables
4.14M 3.13M 3.05M 2.49M
Deferred Revenue
n/a 2M n/a n/a
Short-Term Debt
423K 264K 190K n/a
Other Current Liabilities
7.65M 2.3M 2.29M 2.19M
Total Current Liabilities
13.51M 11.9M 9.62M 9.32M
Long-Term Debt
19.82M 19.23M 28.78M 27.48M
Other Long-Term Liabilities
157K 357K 867K 1.41M
Total Long-Term Liabilities
21.64M 22.35M 34.14M 29.19M
Total Liabilities
35.15M 34.25M 43.76M 38.51M
Total Debt
23.36M 23.72M 34.5M 27.48M
Common Stock
18K 17K 17K 16K
Retained Earnings
-294.33M -279.22M -255.53M -208.14M
Comprehensive Income
n/a n/a -0.00 n/a
Shareholders Equity
9.54M 22.69M 42.46M 84.94M
Total Investments
n/a 200K 200K 100K